Corient Capital Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $482K | Buy |
5,708
+316
| +6% | +$26.7K | 0.04% | 347 |
|
2022
Q2 | $455K | Sell |
5,392
-242
| -4% | -$20.4K | 0.03% | 367 |
|
2022
Q1 | $494K | Buy |
5,634
+1,443
| +34% | +$127K | 0.03% | 392 |
|
2021
Q4 | $366K | Sell |
4,191
-6,837
| -62% | -$597K | 0.02% | 454 |
|
2021
Q3 | $902K | Buy |
11,028
+432
| +4% | +$35.3K | 0.07% | 229 |
|
2021
Q2 | $967K | Buy |
10,596
+1,344
| +15% | +$123K | 0.07% | 219 |
|
2021
Q1 | $791K | Buy |
9,252
+833
| +10% | +$71.2K | 0.07% | 229 |
|
2020
Q4 | $795K | Sell |
8,419
-3,202
| -28% | -$302K | 0.08% | 203 |
|
2020
Q3 | $1.01M | Buy |
11,621
+225
| +2% | +$19.6K | 0.12% | 162 |
|
2020
Q2 | $995K | Buy |
11,396
+67
| +0.6% | +$5.85K | 0.12% | 157 |
|
2020
Q1 | $934K | Sell |
11,329
-4,297
| -27% | -$354K | 0.15% | 130 |
|
2019
Q4 | $1.48M | Sell |
15,626
-592
| -4% | -$56K | 0.19% | 123 |
|
2019
Q3 | $1.41M | Sell |
16,218
-921
| -5% | -$80.1K | 0.2% | 125 |
|
2019
Q2 | $1.57M | Sell |
17,139
-2,465
| -13% | -$225K | 0.24% | 108 |
|
2019
Q1 | $1.69M | Sell |
19,604
-598
| -3% | -$51.5K | 0.27% | 106 |
|
2018
Q4 | $1.55M | Buy |
20,202
+1,520
| +8% | +$117K | 0.28% | 106 |
|
2018
Q3 | $1.44M | Hold |
18,682
| – | – | 0.24% | 120 |
|
2018
Q2 | $1.27M | Buy |
18,682
+2,301
| +14% | +$156K | 0.22% | 131 |
|
2018
Q1 | $1.19M | Buy |
16,381
+4,535
| +38% | +$328K | 0.22% | 114 |
|
2017
Q4 | $891K | Sell |
11,846
-876
| -7% | -$65.9K | 0.15% | 142 |
|
2017
Q3 | $979K | Sell |
12,722
-233
| -2% | -$17.9K | 0.19% | 122 |
|
2017
Q2 | $969K | Buy |
12,955
+334
| +3% | +$25K | 0.15% | 140 |
|
2017
Q1 | $840K | Buy |
12,621
+2,030
| +19% | +$135K | 0.13% | 154 |
|
2016
Q4 | $691K | Sell |
10,591
-1,493
| -12% | -$97.4K | 0.12% | 168 |
|
2016
Q3 | $855K | Buy |
+12,084
| New | +$855K | 0.16% | 139 |
|